Healthcare

FDA Approves Foundayo: Breakthrough Weight Loss Medication

April 2, 2026

Healthcare

Lilly’s orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial

January 24, 2026